Analysts’ Viewpoint on Non-invasive Brain Stimulation System Market Scenario
Non-invasive technology is making revolutionary changes in the healthcare industry. It provides advantages such as less pain, reduced discomfort, and fast treatment. Non-invasive brain stimulation is a technology used to alter brain activity without an incision. Currently, therapeutic drugs are the primary treatment options for diseases such as depression, epilepsy, Parkinson’s disease, and chronic pain. Non-invasive brain stimulation is used when drug treatment fails or is ineffective. The number of patients with depression, epilepsy, and other brain related disorders has increased over the last few years. Key medical devices manufacturers are focusing on design and development of new devices for non-invasive brain stimulation.
Non-invasive brain stimulation is a set of technologies and techniques used to stimulate or alter brain activity from the surface of the head without the introduction of instruments inside the body or breaking the skin. Transcranial magnetic stimulation (TMS) and Transcranial Current Stimulation (TCS) are the two primary methods of non-invasive brain stimulation. The process of transcranial magnetic stimulation involves the production of magnetic pulses easily transferable to the skull and other matter present in the brain. An electrical potential is created in the brain that depolarizes neurons present there and triggers various actions. Transcranial magnetic stimulation (TMS) system is most commonly used in depression, when other depression treatments prove ineffective. Transcranial current stimulation includes alternating current (AC) or direct current (DC), with one electrode put on the head and the other on the target area of the brain.
Non-invasive brain stimulation system is most commonly used in diseases such as depression, epilepsy, Parkinson’s disease, and chronic pain. Incidence of these diseases has increased in countries such as India, China, and Brazil. The global non-invasive brain stimulation system market demand is driven by the increase in preference for non-invasive technology and rise in number of patients suffering from depression and Parkinson’s disease.
Preference for non-invasive technology, especially brain stimulation, has increased over the last few years. Non-invasive procedures are performed without anesthesia. Non-invasive technology causes minimal complications, reduces the risk of infections, causes less pain & discomfort, and offers rapid recovery. This leads to shorter hospital stay than traditional therapies and treatments.
The burden of brain-related disorders is expected to rise significantly across the globe in the next few years. According to the World Health Organization, depression is a leading cause of disability across the world, and is a major contributor to the overall global burden of the disease. Around 280 million people in the world suffer from depression. China accounts for the largest number of people with Parkinson’s disease in the world. Currently, around 2.5 million people in the country are afflicted with the disease. This number is expected to double by the end of 2030, accounting for 50% of the global population. Currently, 1.7% of the population above the age of 65 is affected by the Parkinson’s disease in China.
In terms of product type, the transcranial magnetic stimulation (TMS) system segment accounted for significant market share in 2021. Transcranial magnetic stimulation is a noninvasive treatment used for depression. It is employed when other depression treatments have been ineffective. Transcranial magnetic stimulation (TMS) includes deep transcranial magnetic stimulation and repetitive transcranial magnetic stimulation. As per non-invasive brain stimulation system market analysis, increase in research & development activities in transcranial magnetic stimulation (TMS) products is likely to drive the segment during the forecast period. Surge in usage of TMS in the treatment of disorders such as depression, epilepsy, and Parkinson’s diseases is likely to propel the segment during forecast period. Key market players are focusing on launching innovative products. This is projected to augment the segment. For instance, in March 2021, MagVenture introduced MagVenture Flow Arm used in non-invasive brain stimulation.
Based on application, the depression segment held major share of the global non-invasive brain stimulation system market in 2021. Increase in incidence of depressive disorders is anticipated to drive the segment. According to the World Health Organization, an estimated 5% of adults suffer from depression across the globe. The global non-invasive brain stimulation system market trends indicate that major players are focusing on the launch of new devices for the treatment of depression. This is likely to augment the depression segment. For instance, in March 2020, Neuronetics launched NeuroStar, which is the first transcranial magnetic stimulation (TMS) device to receive Breakthrough Device Designation for bipolar depression.
In terms of end-user, the hospitals segment is expected to account for major share of the global non-invasive brain stimulation system market during the forecast period. Well-established health care infrastructure, favorable medical reimbursement facilities for non-invasive brain stimulation systems in developed countries, and comparative high cost of devices contributed to the segment's large market share in 2021. Furthermore, rise in number of hospitals in developing countries and growth in number of neurological disorders are likely to drive the segment during the forecast period
North America held the largest share of around 40% of the global non-invasive brain stimulation system market in 2021. The region is expected to be a highly lucrative market during the forecast period. North America's dominance of the global market can be ascribed to the increase in incidence of major neurological diseases in the region. The U.S. dominated the market in North America owing to factors such as presence of key market players and increase in the research & development activities in the non-invasive brain stimulation field.
Asia Pacific is projected to be the fastest growing region of the global non-invasive brain stimulation system market during the forecast period. The market in the region is anticipated to grow at a rapid pace from 2022 to 2031 due to high incidence rate of depression, epilepsy, and Parkinson’s disease.
The global non-invasive brain stimulation system market is fragmented, with the presence of large number of leading players. Most of the companies are investing significantly in research & development activities, primarily to introduce innovative products. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by key players operating in the global non-invasive brain stimulation system market. Brainbox Ltd., BrainsWay, eNeura Inc., Flow Neuroscience, Magnus Medical, Inc., Magstim, MagVenture, NeoSync, Inc. (Wave Neuroscience, Inc.), NeuraLace, Neurocare Group AG, NeuroMetrix, Neuronetics, and Soterix Medical, Inc. are the prominent players operating in the market.
Each of these players has been profiled in the non-invasive brain stimulation system market report based on parameters such as company overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 580.3 Mn |
|
Market Forecast Value in 2031 |
More than US$ 1.04 Bn |
|
Growth Rate (CAGR) |
6.3% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global non-invasive brain stimulation market was valued at US$ 580.3 Mn in 2021
The global non-invasive brain stimulation market is projected to reach more than US$ 1.04 Bn by 2031
The global non-invasive brain stimulation market is anticipated to grow at a CAGR of 6.3% from 2022 to 2031
Increase in preference for non-invasive technology, and rise in incidence of depression and Parkinson’s disease
North America is likely to account for major share of the global non-invasive brain stimulation market during the forecast period
Brainbox Ltd., BrainsWay, eNeura Inc., Flow Neuroscience, Magnus Medical, Inc., Magstim, MagVenture, NeoSync, Inc. (Wave Neuroscience, Inc.), NeuraLace, Neurocare Group AG, NeuroMetrix, Neuronetics, and Soterix Medical, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Non-invasive Brain Stimulation System Market Forecast
4.4. Global Non-invasive Brain Stimulation System Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Key product/Brand Analysis
5.3. Diseases Epidemiology
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type
6.1. Introduction
6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type
6.3.1. Transcranial Magnetic Stimulation (TMS) System
6.3.2. Transcranial Current Stimulation (TCS) System
6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type
7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application
7.3.1. Depression
7.3.2. Epilepsy
7.3.3. Parkinson’s Disease
7.3.4. Chronic Pain
7.3.5. Others
7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application
8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialty Clinics
8.3.4. Others
8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user
9. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region
9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Non-invasive Brain Stimulation System Market Analysis
10.1. North America Non-invasive Brain Stimulation System Market Overview
10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type
10.5.1. Transcranial Magnetic Stimulation (TMS) System
10.5.2. Transcranial Current Stimulation (TCS) System
10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application
10.7.1. Depression
10.7.2. Epilepsy
10.7.3. Parkinson’s Disease
10.7.4. Chronic Pain
10.7.5. Others
10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Ambulatory Surgical Centers
10.9.3. Specialty Clinics
10.9.4. Others
11. Europe Non-invasive Brain Stimulation System Market Analysis
11.1. Europe Non-invasive Brain Stimulation System Market Overview
11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type
11.5.1. Transcranial Magnetic Stimulation (TMS) System
11.5.2. Transcranial Current Stimulation (TCS) System
11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application
11.7.1. Depression
11.7.2. Epilepsy
11.7.3. Parkinson’s Disease
11.7.4. Chronic Pain
11.7.5. Others
11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Ambulatory Surgical Centers
11.9.3. Specialty Clinics
11.9.4. Others
12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis
12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview
12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type
12.5.1. Transcranial Magnetic Stimulation (TMS) System
12.5.2. Transcranial Current Stimulation (TCS) System
12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application
12.7.1. Depression
12.7.2. Epilepsy
12.7.3. Parkinson’s Disease
12.7.4. Chronic Pain
12.7.5. Others
12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Ambulatory Surgical Centers
12.9.3. Specialty Clinics
12.9.4. Others
13. Latin America Non-invasive Brain Stimulation System Market Analysis
13.1. Latin America Non-invasive Brain Stimulation System Market Overview
13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type
13.5.1. Transcranial Magnetic Stimulation (TMS) System
13.5.2. Transcranial Current Stimulation (TCS) System
13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application
13.7.1. Depression
13.7.2. Epilepsy
13.7.3. Parkinson’s Disease
13.7.4. Chronic Pain
13.7.5. Others
13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Ambulatory Surgical Centers
13.9.3. Specialty Clinics
13.9.4. Others
14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis
14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview
14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type
14.5.1. Transcranial Magnetic Stimulation (TMS) System
14.5.2. Transcranial Current Stimulation (TCS) System
14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application
14.7.1. Depression
14.7.2. Epilepsy
14.7.3. Parkinson’s Disease
14.7.4. Chronic Pain
14.7.5. Others
14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Ambulatory Surgical Centers
14.9.3. Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Brainbox Ltd.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. BrainsWay
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. eNeura, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. Flow Neuroscience
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Magnus Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Magstim
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. MagVenture
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. NeuraLace
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. neurocare group AG
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. NeuroMetrix
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. Neuronetics
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Soterix Medical, Inc.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Strategic Overview
List of Tables
Table 01: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Brainbox Ltd. Business Overview
Table 26: BrainsWay Business Overview
Table 27: eNeura Inc. Overview
Table 28: Flow Neuroscience Business Overview
Table 29: Magnus Medical, Inc. Business Overview
Table 30: Magstim Business Overview
Table 31: MagVenture Business Overview
Table 32: NeoSync, Inc. (Wave Neuroscience, Inc.) Business Overview
Table 33: NeuraLace Business Overview
Table 34: neurocare group AG Business Overview
Table 35: NeuroMetrix Business Overview
Table 36: Neuronetics Business Overview
Table 37: Soterix Medical, Inc.Business Overview
List of Figures
Figure 01: Market Share, by Product Type
Figure 02: Market Share, by Application
Figure 03: Market Share, by Region
Figure 04: Global Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast, 2017–2031
Figure 05: Global Non-invasive Brain Stimulation System Market Value Share, by Product Type, 2021
Figure 06: Global Non-invasive Brain Stimulation System Market Value Share, by End-user, 2021
Figure 07: Global Non-invasive Brain Stimulation System Market Value Share, by Application, 2021
Figure 08: Global Non-invasive Brain Stimulation System Market Value Share, by Region, 2021
Figure 09: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 10: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 11: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Magnetic Stimulation (TMS) System, 2017–2031
Figure 12: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Transcranial Current Stimulation (TCS) System, 2017–2031
Figure 13: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 14: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 15: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Depression, 2017–2031
Figure 16: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Epilepsy, 2017–2031
Figure 17: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Parkinson’s Disease, 2017–2031
Figure 18: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Chronic Pain, 2017–2031
Figure 19: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017–2031
Figure 20: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 21: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Figure 22: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 23: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 24: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Specialty Clinic, 2017–2031
Figure 25: Global Non-invasive Brain Stimulation System Market Revenue (US$ Mn), by Others, 2017–2031
Figure 26: Global Non-invasive Brain Stimulation System Market Value Share Analysis, by Region, 2021 and 2031
Figure 27: Global Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Region, 2022-2031
Figure 28: North America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 29: North America Non-invasive Brain Stimulation System Market Value Share (%), by Country, 2021 and 2031
Figure 30: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country, 2022–2031
Figure 31: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 32: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 33: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 34: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 35: North America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 36: North America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Figure 37: Europe Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 38: Europe Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 39: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 40: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 41: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 42: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 43: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 44: Europe Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 45: Europe Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Figure 46: Asia Pacific Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 47: Asia Pacific Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 48: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 49: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 50: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 51: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 52: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 53: Asia Pacific Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 54: Asia Pacific Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 56: Latin America Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 57: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 58: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 59: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 60: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 61: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 62: Latin America Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 63: Latin America Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Figure 64: Middle East & Africa Non-invasive Brain Stimulation System Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 65: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 66: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 67: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 68: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 69: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by Application, 2021 and 2031
Figure 70: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by Application, 2022–2031
Figure 71: Middle East & Africa Non-invasive Brain Stimulation System Market Value Share Analysis, by End-user, 2021 and 2031
Figure 72: Middle East & Africa Non-invasive Brain Stimulation System Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Non-invasive Brain Stimulation System Market
